Skull base plasmacytoma in young patients aged below 40 years: Radiological perspectives and clinical outcomes
Cancer Reports · 2024
DOI: 10.1002/cnr2.2106 ↗Kurz gefasst
Fallbericht in der Zeitschrift Cancer Reports, 2024. Verfasst von Hesham Elsabah und 10 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hematology, Department of Medical Oncology, National Center for Cancer Care & Research (NCCCR), Hamad Medical Corporation (HMC), Doha, Qa…. Hauptthemen laut MEDLINE: Plasmacytoma, Skull Base Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Plasmacytoma of the skull base is a rare manifestation of plasma cell neoplasm with only a few cases documented in literature involving young adults. Plasmacytoma can be an isolated solitary lesion or a secondary manifestation of multiple myeloma (MM). In this study, we report the clinical and radiological characteristics, management, and outcomes of patients under the age of 40 who presented with skull base plasmacytoma and associated neurological manifestations. Additionally, we share our experience in treating a rare case of skull base plasmacytoma diagnosed during pregnancy, in which the patient exhibited a favorable response to myeloma treatment initiated after delivery. Case Series Four patients were identified, comprising one pregnant female and three male patients, with a median age of 36 years (range 33–37 years). The main presenting symptoms were headache, dizziness, and cranial nerve palsy. All patients received underwent systemic myeloma therapy and radiotherapy with three patients also underwent autologous stem cell transplantation (ASCT). Notably, all patients achieved complete remission.
Conclusion
Skull base plasmacytoma represents a rare manifestation of plasma cell neoplasms, underscoring the importance of considering it in the differential diagnosis of skull base lesions to ensure early intervention and avoid potential serious complications. Throughout our series, the cornerstone of therapy involved radiotherapy, systemic myeloma therapy, and ASCT, all of which elicited a favorable response in every case.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Hematology, Department of Medical Oncology, National Center for Cancer Care & Research (NCCCR), Hamad Medical Corporation (HMC), Doha, Qatar.
- Department of Pharmacy, National Center for Cancer Care & Research (NCCCR), Hamad Medical Corporation (HMC), Doha, Qatar.
- Department of Laboratory Medicine and Pathology, National Center for Cancer Care & Research (NCCCR), Hamad Medical Corporation (HMC), Doha, Qatar.
- Department of Laboratory Medicine and Pathology, Weill Cornell Medical College (WCMC-Q), Doha, Qatar.
- Department of Clinical Pathology, National Cancer Institute, Cairo, Egypt.
- Internal Medicine, Unity hospital, Rochester Regional Health, Rochester, New York, USA.
ORCID-Profile: Rola Ghasoub
Zitieren
APA
Elsabah, H., Ghasoub, R., Soliman, D. S., Ibrahim, F., Aldapt, M. B., Taha, R. Y., Al Azawi, S., Mudawi, D., Moustafa, A., Elomri, H., & Cherif, H. (2024). Skull base plasmacytoma in young patients aged below 40 years: Radiological perspectives and clinical outcomes. Cancer Reports. https://doi.org/10.1002/cnr2.2106
Vancouver
Elsabah H, Ghasoub R, Soliman DS, Ibrahim F, Aldapt MB, Taha RY, et al. Skull base plasmacytoma in young patients aged below 40 years: Radiological perspectives and clinical outcomes. Cancer Reports. 2024. doi:10.1002/cnr2.2106
BibTeX
@article{Elsabah2024,
author = {Elsabah, Hesham and Ghasoub, Rola and Soliman, Dina S and Ibrahim, Feryal and Aldapt, Mahmood B and Taha, Ruba Y and Al Azawi, Safaa and Mudawi, Deena and Moustafa, Abbas and Elomri, Halima and Cherif, Honar},
title = {Skull base plasmacytoma in young patients aged below 40 years: Radiological perspectives and clinical outcomes},
journal = {Cancer Reports},
year = {2024},
doi = {10.1002/cnr2.2106}
}
EUVIMED